CD8A and esophageal squamous cell carcinoma: In summary, although similar transition trajectories were observed in CD8+ T cells from NACT-ESCC and SA-ESCC samples, different immune and transcriptional states were detected, indicating that different immunotherapeutic strategies should be considered for the treatment of SA-ESCC and NACT-ESCC patients.